RJF — Laboratorio Reig Jofre SA Income Statement
0.000.00%
Last trade - 00:00
- €245.06m
- €295.50m
- €316.09m
- 86
- 43
- 70
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 200 | 230 | 236 | 271 | 316 |
Cost of Revenue | |||||
Gross Profit | 132 | 144 | 148 | 161 | 184 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 194 | 221 | 227 | 263 | 306 |
Operating Profit | 6.32 | 9.23 | 8.86 | 8.53 | 10.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.3 | 6.43 | 5.79 | 8.76 | 10.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.94 | 5.67 | 5.08 | 8.11 | 9.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.94 | 5.67 | 5.09 | 8.11 | 9.41 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.94 | 5.67 | 5.09 | 8.11 | 9.41 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.069 | 0.076 | 0.214 | 0.114 | 0.139 |